Invasive candidiasis following liver transplantation and surgical complications

Mycoses

Volumn 54, Issue SUPPL. 4, 2011, Pages 4-7

  Auzinger, Georg ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Acute liver failure; Anidulafungin; Echinocandins; Invasive candidiasis; Liver transplantation

Indexed keywords

ACETYLCYSTEINE; AMIKACIN; ANIDULAFUNGIN; CALCINEURIN INHIBITOR; DACLIZUMAB; FLUCONAZOLE; NORADRENALIN; PARACETAMOL; PIPERACILLIN PLUS TAZOBACTAM;

ACUTE LIVER FAILURE; ADULT; ANAMNESIS; ANTIBIOTIC PROPHYLAXIS; ARTICLE; CANDIDA GLABRATA; CASE REPORT; DRUG OVERDOSE; EMERGENCY SURGERY; GRAFT REJECTION; HUMAN; INVASIVE CANDIDIASIS; LIVER TRANSPLANTATION; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIPLE ORGAN FAILURE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STENOTROPHOMONAS MALTOPHILIA; SUICIDE ATTEMPT; TREATMENT DURATION; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ADULT; ANTIFUNGAL AGENTS; CANDIDIASIS, INVASIVE; ECHINOCANDINS; HUMANS; IMMUNOCOMPROMISED HOST; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; POSTOPERATIVE COMPLICATIONS; TREATMENT OUTCOME;

EID: 82455192554     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/j.1439-0507.2011.02135.x     Document Type: Article

References (19)

1. Schroter GPJ, Hoelscher M, Putnam CW, Porter KA, Starzl TE. Fungus infections after liver transplantation. Ann Surg 1977; 186: 115-22.
2. Fortun J, Martin-Davila P, Moreno S et al. Prevention of invasive fungal infections in liver transplant recipients: the role of prophylaxis with lipid formulations of amphotericin B in high-risk patients. J Antimicrob Chemother 2003; 52: 813-19.
3. Gavalda J, Len O, San Juan R et al. Risk factors for invasive aspergillosis in solid-organ transplant recipients: a case-control study. Clin Infect Dis 2005; 41: 52-59.
4. Saner FH, Olde Damink SWM, Pavlakovic G et al. Pulmonary and blood stream infections in adult living donor and cadaveric liver transplant patients. Transplantation 2008; 85: 1564-8.
5. Pappas PG, Alexander DB, Andes DR et al. Invasive fungal infections among organ transplant recipients: results of the transplant-associated infection surveillance network (TRANSNET). Clin Infect Dis 2010; 50: 1101-11.
6. Karvellas CJ, Pink F, McPhail M et al. Predictors of bacteraemia and mortality in patients with acute liver failure. Intensive Care Med 2009; 35: 1390-6.
7. Guery BP, Arendrup MC, Auzinger G et al. Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. epidemiology and diagnosis. Intensive Care Med 2009; 35: 55-62.
8. Gabardi S, Kubiak DW, Chandraker AK, Tullius SG. Invasive fungal infections and antifungal therapies in solid organ transplant recipients. Transpl Int 2007; 20: 993-1015.
9. Singh N, Wagenar MM, Cacciarelli TV, Levitsky J. Antifungal management practices in liver transplant recipients. Am J Transplant 2008; 8: 426-31.
10. Husain S, Tollemar J, Dominguez EA et al. Changes in the spectrum and risk factors for invasive candidiasis in liver transplant recipients: prospective, multicentre, case-controlled study. Transplantation 2003; 75: 2023-9.
11. Lockhart SR, Wagner D, Iqbal N et al. Comparison of in vitro susceptibility characteristics of Candida species from cases of invasive candidiasis in solid organ and stem cell transplant recipients: transplant-associated infections surveillance network (TRANSNET), 2001 to 2006. J Clin Microbiol 2011; 49: 2404-10.
12. Pappas PG, Kauffman CA, Andes D et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the infectious diseases society of America. Clin Infect Dis 2009; 48: 503-35.
13. Playford EG, Eggimann P, Calandra T. Antifungals in the ICU. Curr Opin Infect Dis 2008; 21: 610-9.
14. McMullan R, Metwally L, Coyle PV et al. A prospective clinical trial of a real-time polymerase chain reaction assay for the diagnosis of candidemia in nonneutropenic, critically ill adults. Clin Infect Dis 2008; 46: 890-6.
15. Parkins MD, Sabuda DM, Elsayed S, Laupland KB. Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections. J Antimicrob Chemother 2007; 60: 613-8.
16. Anidulafungin. Summary of product characteristics. 2010. URL [accessed on February 2011].
17. Ostrosky-Zeichner L, Sable C, Sobel J et al. Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting. Eur J Clin Microbiol Infect Dis 2007; 26: 271-6.
18. Eggimann P, Francioli P, Bille J et al. Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients. Crit Care Med 1999; 27: 1066-72.
19. Vazquez JA, Sobel JD. Anidulafungin: a novel echinocandin. Clin Infect Dis 2006; 43: 215-22.